Interferential current is effective in palmar psoriasis: An open prospective trial

European Journal of Dermatology

Volumn 10, Issue 3, 2000, Pages 195-198

  Philipp, Armin ^a   Wolf, Gerhard K ^b   Rzany, Berthold ^a   Dertinger, Hermann ^c   Jung, Ernst G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Klinisches Forschungsinstitut   (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Clinical trial; Interferential current; Psoriasis; Shifted null hypothesis

Indexed keywords

ANTIPSORIASIS AGENT; CYCLIC AMP; CYCLIC GMP; RETINOL; VITAMIN D DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEVICE; DIATHERMY; ERYTHEMA; HUMAN; PUSTULOSIS PALMOPLANTARIS; REMISSION; TREATMENT OUTCOME;

ADULT; ELECTRIC STIMULATION THERAPY; FEMALE; HAND DERMATOSES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; TREATMENT OUTCOME;

EID: 0034026072     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. 1. Eriksson M, Hagforsen E, Lundin I. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol 1998; 138: 390-8.
2. 2. Derancourt C, Van Landuyt, Laurent R. Le Psoriasis Palmo-Plantaire: diagnostic et stratégie thérapeutique. Ann Dermatol Venereol 1998; 125: 220-5.
3. 3. Kumar B, Kumar R, Kaur I. Coal tar therapy in palmoplantar psoriasis: old wine in an old bottle. Int J Dermatol 1997; 36: 309-12.
4. 4. Wolf SM. Interferenzstrom-Therapie. Ekktromedizin 1956; 1: 77-80.
5. 5. Nikolova L. Treatment with interferential current. Churchill Livingstone, Edinburgh-London-Melbourne-New York 1987.
6. 6. Ward AR. Fields and Waves in Therapy. Science Press 1980; Fitzroy and Chapel Streets, Marrikville NSW 2204, Australia.
7. 7. Wolf B, Dertinger H, Wolf G. Die Wirkung von Interferenzstrom auf Psoriasis vulgaris. Akt Dermatol 1996; 22: 94-7.
8. 8. Altmeyer PJ, Matthes U, Pawlak F, et al. Antipsoriatic effect of fumaric acid derivatives. J Am Acad Dermatol 1994; 30: 977-81.
9. 9. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
10. 10. Bauer P, Köhne K Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50: 1029-41. [Correction in Biometrics 1996;52: 380].
11. 11. Knedlitschek G, Noszvai-Nagy M, Meyer-Waarden H, et al. Cyclic AMP response in cells exposed to electric fields of different frequencies and intensities. Radiat Environ Biophys 1994; 33: 141-7.
12. 12. Sontag W, Dertinger H. Response of cytosolic calcium, cyclic AMP and cyclic GMP in DMSO-differentiated HL-60 cells to modulated low frequency electric currents. Bioelectromagnetics 1998; in press.
13. 13. Voorhees JJ, Duell EA. Imbalanced cyclic AMP-cyclic AMP levels in psoriasis. In: Advances in Cyclic Nucleotide Research Vol. 5 (GI Drummond, P Greengard, GA Robinson, Eds.) 1975; Raven Press, New York, 735-58.
14. 14. Royer E, Chaintreul J, Meynadier J, et al. Cyclic AMP and cyclic GMP productionin normal and psoriatic epidermis. Dermatologica 1982; 165: 533-43.